FDA inspection
International Medication Systems Ltd.: FDA inspection ending Mar 16, 2006
FDA inspection 418736 · Voluntary Action Indicated (VAI) · South El Monte, CA
Key facts
| Inspection ID | 418736 |
|---|---|
| Firm | International Medication Systems Ltd. |
| FEI number | 2016148 |
| Address | 1886 Santa Anita Ave |
| City | South El Monte |
| State | CA |
| ZIP | 91733-3414 |
| Fiscal year | 2006 |
| Inspection end date | Mar 16, 2006 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Drug Quality Assurance|New Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs |
| Product type | Devices, Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data